Medicare Enrolled
Dr. Adam Nassery, MD
Interventional Pain Medicine Physician · Aventura, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Nassery from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Nassery?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Nassery
Dr. Adam Nassery is an interventional pain medicine physician in Aventura, FL, with 11 years of NPI registration. Based on federal Medicare data, Dr. Nassery performed 7,625 Medicare services across 2,092 unique beneficiaries.
Between the years covered by Open Payments, Dr. Nassery received a total of $25,517 from 48 pharmaceutical and/or device companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional pain medicine physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Nassery is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 11 years in practice
▲ Top 19% volume in FL
$25,517 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 140811 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗7,625
Medicare services
Top 19% in FL for interventional pain medicine physician
2,092
Unique beneficiaries
$54
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~693 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
3,023 | $1 | $9 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
858 | $101 | $920 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
781 | $0 | $1 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
517 | $67 | $643 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
447 | $106 | $913 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
275 | $75 | $644 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
251 | $144 | $1,414 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
214 | $97 | $807 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
177 | $54 | $513 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
164 | $210 | $1,874 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
136 | $186 | $2,008 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
104 | $106 | $968 |
| Drug screening test A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample. |
80 | $61 | $249 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
67 | $36 | $451 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
57 | $137 | $1,123 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
49 | $153 | $626 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
40 | $215 | $1,906 |
| Psychological test administration, first 30 minutes A technician administers psychological or neuropsychological testing for the first 30 minutes. |
38 | $28 | $238 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
37 | $203 | $1,577 |
| New patient office visit, complex (60-74 min) | 36 | $186 | $1,587 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
35 | $134 | $1,219 |
| Hyaluronan injection (Euflexxa) for joint An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space. |
34 | $98 | $561 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
32 | $259 | $1,941 |
| Neuropsychological test evaluation, first hour A professional assessment of cognitive and behavioral functioning using standardized tests. This service covers the initial hour of the evaluation process. |
27 | $107 | $908 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
25 | $172 | $1,537 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
24 | $148 | $1,254 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $151 | $1,280 |
| Definitive drug test using GC/MS or LC/MS A definitive drug test that identifies specific drugs and distinguishes between structural isomers using advanced methods like GC/MS or LC/MS. |
20 | $242 | $988 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
19 | $32 | $398 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
19 | $110 | $811 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
18 | $99 | $794 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$25,517
Total received (2018-2024)
Avg $3,645/year across 7 years
Top 10% in FL for interventional pain medicine physician
48
Companies
545
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$19,975 (78.3%)
Scientific / Research
Research funding and grants
$3,636 (14.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,906 (7.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$5,069
2023
$3,109
2022
$4,557
2021
$5,951
2020
$1,727
2019
$1,706
2018
$3,399
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$8,704
BIOTRONIK NRO, Inc.
$5,770
BOSTON SCIENTIFIC CORPORATION
$3,270
Spinal Simplicity, LLC
$2,039
Vertos Medical, Inc.
$722
Boston Scientific Corporation
$521
Scilex Pharmaceuticals Inc.
$479
Medtronic USA, Inc.
$438
SCILEX PHARMACEUTICALS INC.
$377
SPR Therapeutics, Inc
$331
RedHill Biopharma Inc.
$320
Medtronic, Inc.
$296
Forte Bio-Pharma LLC
$208
Flowonix Medical Incorporated
$143
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$142
Nevro Corp.
$134
PFIZER INC.
$131
Collegium Pharmaceutical, Inc.
$120
FORTE BIO-PHARMA LLC
$116
Amniox Medical, Inc.
$115
Stimwave Technologies Incorporated
$113
Relievant Medsystems, Inc.
$106
BioDelivery Sciences International, Inc.
$99
Biohaven Pharmaceutical Holding Company Ltd.
$56
Teva Pharmaceuticals USA, Inc.
$56
Sentynl Therapeutics, Inc.
$54
Almatica Pharma LLC
$53
Valinor Pharma, LLC
$52
Merz Pharmaceuticals, LLC
$51
US WorldMeds, LLC
$48
Kowa Pharmaceuticals America, Inc.
$43
Averitas Pharma Inc.
$40
SI-BONE, INC.
$40
DePuy Synthes Sales Inc.
$35
Avanos Medical
$29
VERTEX PHARMACEUTICALS INCORPORATED
$27
Alnylam Pharmaceuticals Inc.
$25
Azurity Pharmaceuticals, Inc.
$25
Masimo Corporation
$24
ARGENX US, INC.
$23
Virtus Pharmaceuticals LLC
$22
SI-BONE, Inc.
$21
Curonix LLC
$21
Medline Industries, Inc.
$19
Nalu Medical, Inc.
$16
IBSA Pharma Inc.
$14
Hikma Pharmaceuticals USA
$14
GRT US Holding, Inc.
$13
Top 3 companies account for 69.5% of total payments
Associated products mentioned in payments ›
AUSTEDO · Austedo XR · BELBUCA · BIOTRONIK · BUNAVAIL 2.1 mg 30-count box · COMIRNATY · COOLIEF* COOLED RADIOFREQUENCY · Custom Anesthesia Procedure Packs · ETERNA · GENERAL PAIN MANAGEMENT · GENERAL - PAIN MANAGEMENT · GIVLAARI · GRALISE · HA MINUTEMAN G3-R · HORIZANT · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON Balloon Kyphoplasty · KYPHON EXPRESS II KYPHOPAK TRAY · Kloxxado · LEVORPHANOL TARTRATE · LICART · Levorphanol Tartrate · Livalo · MONOVISC · MOVANTIK · MYOBLOC · Movantik · NALOCET · NEOX · NURTEC ODT · Nalocet · Nalu Neurostimulation System · PACEL · PAXLOVID · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROCLAIM · PRODIGY · PROLATE · Patient SafetyNet System · Proclaim Family of SCS IPGs · Proclaim IPG · Prodigy Family of SCS IPGs · Prometra II · Prospera · QUTENZA · Qutenza · RELISTOR · SEGLENTIS · SPECTRA WAVEWRITER · SPRINT PNS System · SYNCHROMED · Senza Spinal Cord Stimulation System · StimQ Peripheral Nerve StimulatorSystem · VYVGART HYTRULO · WAVEWRITER ALPHA · XTAMPZA · Xeomin · ZTLido · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (78%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for interventional pain medicine physician in FL.
Equivalent to $335 per 100 Medicare services performed
Geographic Context
Interventional pain medicine physicians within 10 mi
34
Per 100K population
1.3
County median income
$68,694
Nearest hospital
HCA FLORIDA AVENTURA HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Nassery is a mixed practice specialist, with above-average Medicare volume (top 19% in FL), with low-engagement industry engagement in the top 10% of FL peers.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Nassery experienced with steroid injection (triamcinolone)?
Based on Medicare claims data, Dr. Nassery performed 3,023 steroid injection (triamcinolone) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Nassery receive payments from pharmaceutical companies?
Yes. Dr. Nassery received a total of $25,517 from 48 companies across 545 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Nassery's costs compare to other interventional pain medicine physicians in Aventura?
Dr. Nassery's average Medicare payment per service is $54. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Nassery) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Interventional Pain Medicine Physicians in Aventura
Browse interventional pain medicine physicians in Aventura ranked by procedure volume and transparency data.
Highest volume
Top Interventional Pain Medicine Physicians in FL
Interventional pain medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Pain Medicine Physicians in FL
Which FL interventional pain medicine physicians receive the most from drug and device companies.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
By company
BIOTRONIK NRO, Inc. Payments to Doctors
See all physicians who received payments from BIOTRONIK NRO, Inc.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology